Exploring health literacy pertaining to general wellbeing and chronic disease management among population registered within Primary Healthcare System: A Study protocol

Exploring health literacy pertaining to general wellbeing and chronic disease management among population registered within Primary Healthcare System: A Study protocol

Abstract Background Evidence suggests that high level of health literacy among patients is associated with high…

Continue Reading
Information technology perception and value cocreation behavior influence patient satisfaction in chronic disease care

Information technology perception and value cocreation behavior influence patient satisfaction in chronic disease care

Milani, R. V. & Lavie, C. J. Health care 2020: reengineering health care delivery to combat…

Continue Reading
AI-Driven Rare Disease Patient Finder Market Report 2025 –

AI-Driven Rare Disease Patient Finder Market Report 2025 –

Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) — The “Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market…

Continue Reading
User-needs based app for patients with inflammatory bowel disease: development and usability study | BMC Health Services Research

User-needs based app for patients with inflammatory bowel disease: development and usability study | BMC Health Services Research

Study design The progress of this study is presented in (Fig. 1). Co-design, also referred to as…

Continue Reading
Effectiveness of digital healthcare to improve clinical outcomes in discharged patients with coronary artery disease

Effectiveness of digital healthcare to improve clinical outcomes in discharged patients with coronary artery disease

Digital medical management after discharge represents a new approach to chronic disease management, leveraging technologies such…

Continue Reading
Donanemab licensed for early stages of Alzheimer’s disease in adult patients who have one or no copies of apolipoprotein E4 gene

Donanemab licensed for early stages of Alzheimer’s disease in adult patients who have one or no copies of apolipoprotein E4 gene

Donanemab works by removing a sticky protein called beta-amyloid from the brain that is believed to…

Continue Reading